Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-24-048745
Filing Date
2024-12-04
Accepted
2024-12-04 21:24:01
Documents
1
Period of Report
2024-12-02

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3887
  Complete submission text file 0001493152-24-048745.txt   5628
Mailing Address 800 S. GAY STREET SUITE 1610 KNOXVILLE TN 37929
Business Address 800 S. GAY STREET SUITE 1610 KNOXVILLE TN 37929 (866) 594-5999
PROVECTUS BIOPHARMACEUTICALS, INC. (Issuer) CIK: 0000315545 (see all company filings)

EIN.: 900031917 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 10025 INVESTMENT DRIVE SUITE 250 KNOXVILLE TN 37932
Business Address
Raines Heather (Reporting) CIK: 0001770650 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36457 | Film No.: 241527615